| Literature DB >> 32244822 |
Zubair Ahmed Ratan1,2, Mohammad Faisal Haidere3, Md Nurunnabi4, Sadi Md Shahriar5, A J Saleh Ahammad6, Youn Young Shim1,7,8, Martin J T Reaney7,8, Jae Youl Cho1.
Abstract
Nanobiotechnology has grown rapidly and become an integral part of modern disease diagnosis and treatment. Biosynthesized silver nanoparticles (AgNPs) are a class of eco-friendly, cost-effective and biocompatible agents that have attracted attention for their possible biomedical and bioengineering applications. Like many other inorganic and organic nanoparticles, such as AuNPs, iron oxide and quantum dots, AgNPs have also been widely studied as components of advanced anticancer agents in order to better manage cancer in the clinic. AgNPs are typically produced by the action of reducing reagents on silver ions. In addition to numerous laboratory-based methods for reduction of silver ions, living organisms and natural products can be effective and superior source for synthesis of AgNPs precursors. Currently, plants, bacteria and fungi can afford biogenic AgNPs precursors with diverse geometries and surface properties. In this review, we summarized the recent progress and achievements in biogenic AgNPs synthesis and their potential uses as anticancer agents.Entities:
Keywords: anti-cancer effect; cancer; green chemistry; silver nanoparticles
Year: 2020 PMID: 32244822 DOI: 10.3390/cancers12040855
Source DB: PubMed Journal: Cancers (Basel) ISSN: 2072-6694 Impact factor: 6.639